Success Stories: A Senior Scientist from Taiwan Obtains a National Interest Waiver (NIW) In Less than 3 Months, Now I-485 Approval Awaits

 

Client’s Testimonial:

“I met three immigration firms for my L1b, O1A, and NIW in 2022. I must say that Chen Immigration is the BEST!!!”

---

On January 26^th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Scientist in the Field of Biotechnologies (Approval Notice).

---

General Field: Biotechnologies

Position at the Time of Case Filing: Senior Scientist

Country of Origin: Taiwan

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: January 26^th, 2023

Processing Time: 2 months, 16 days

---

Case Summary:

A holder of a Ph.D. in mechanical engineering hired North America Immigration Law Group to help him file an NIW (National Interest Waiver) petition. We comprehensively assessed his exceptional credentials, and we were convinced that we could help him secure the national interest waiver. We are proud to offer a personalized approach to customizing I-140 petitions, which we believe is a key contributor to our high approval rate. Therefore, our ultimate goal in this case was to demonstrate to the USCIS that our client's proposed research is highly relevant to advancing cell-based therapies for the treatment of diseases such as cancer.

We enclosed the following pointers in his NIW petition packet.

• Our client's proposed endeavor is to utilize microscopy and novel machine-learning models in the cryopreservation of therapeutic cells in order to improve life-saving cell-based medicinal products.
• We conceded the fact that his research is of great importance because it facilitates the implementation of cell-based therapies for a wide range of diseases, including cancers. One of the most common forms of cell therapy, hematopoietic stem cell transplantation, is commonly used to treat blood cancers.
• His publication record includes 7 first-authored peer-reviewed journal articles, 1 first-authored peer-reviewed conference paper, and 2 conference abstracts. His publications have been cited a total of 73 times, thereby demonstrating that these publications are widely recognized and relied upon in the field of biotechnologies. Upon reviewing his citation record, it is evident that he has had a major influence on other scholars’ understanding of topics in the field and has directly benefited from our client’s research.
• Due to his knowledge and expertise in his chosen field, he has been regularly invited to conduct peer reviews for an authoritative journal in the field, and he has completed at least 2 reviews to date.
• After drafting the petition, we also included four recommendation letters from other scholars in the field to bolster our client’s case. Fellow experts in the field provided additional insight into the merit of his proposed endeavor, and one of them stated:

“Although other countries are investing more in the development of cell therapy, the United States leads in the development and clinical trials. The [Client] is making significant contributions to the advancement of the United States' cell therapy industry and the expansion of treatment options for patients nationwide. Therefore, the continuation of his research in the United States is crucial.”

Successfully, we achieved another positive outcome by providing the necessary aid to our esteemed client. With our help, the client was able to obtain NIW approval in a very short amount of time (2 months and 16 days). Our elevated approval rate and efficient case submission process make our services a great option for our clients. Our client’s decision to choose our firm is deeply appreciated, and we are genuinely grateful for the opportunity to assist him. We wish him all the best in his future endeavors, both personally and professionally. May his I-485 approval be granted swiftly, bringing him closer to achieving his green card.

---